Clinical Trial Update: Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluating gemcitabine with or without oxaliplatin in locally advanced or metastatic bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED